- Report
- January 2026
- 506 Pages
Global
From €5186EUR$5,850USD£4,512GBP
- Report
- January 2026
- 363 Pages
Global
From €5186EUR$5,850USD£4,512GBP
- Report
- September 2025
- 250 Pages
Global
From €3980EUR$4,490USD£3,463GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1773EUR$2,000USD£1,543GBP
- Report
- November 2025
- 200 Pages
Global
From €7047EUR$7,950USD£6,132GBP
- Report
- November 2025
- 200 Pages
Global
From €7047EUR$7,950USD£6,132GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1773EUR$2,000USD£1,543GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1773EUR$2,000USD£1,543GBP
- Clinical Trials
- April 2025
- 280 Pages
Global
From €2659EUR$3,000USD£2,314GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1773EUR$2,000USD£1,543GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1773EUR$2,000USD£1,543GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1330EUR$1,500USD£1,157GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1330EUR$1,500USD£1,157GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1330EUR$1,500USD£1,157GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1330EUR$1,500USD£1,157GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1330EUR$1,500USD£1,157GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1108EUR$1,250USD£964GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1108EUR$1,250USD£964GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1108EUR$1,250USD£964GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1108EUR$1,250USD£964GBP

Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more